Peer-reviewedCC BY-NC-SAAnnals of medicine and surgery (2012)
Cost-effectiveness analysis of FundoRing versus standard one-anastomosis gastric bypass: up to 3-year results of a randomized controlled trial
- 1Tsoy Scientific-Educational Center of Surgery, Astana Medical University, Astana, Kazakhstan
- 2Surgery Center of Professor Oral Ospanov, Astana, Kazakhstan
Related
- Effectiveness of integrated tuberculosis and depression treatment led by non-specialist health workers versus standard care among persons with tuberculosis in a low-resource setting: A quasi-experimental non-randomized controlled trial
- Cost-effectiveness of adding enzalutamide vs standard non-steroidal antiandrogen drugs for patients with metastatic hormone-sensitive prostate cancer undergoing standard first-line therapy: a within-trial, secondary end-point analysis of the ENZAMET phase 3, international randomized trial (ANZUP 1304)
- Effectiveness of Nursing Interventions on Stress and Functional Capacity Among Patients After Coronary Artery Bypass Grafting (CABG): A Randomized Controlled Trial
- Effectiveness of behavioral interventions on knowledge, attitude, and adherence to prenatal Multiple Micro-nutrients Suplement among pregnant women in Ethiopia: a post-test only cluster randomized controlled trial
- Effectiveness, Safety, and Cost-Effectiveness of Ultrasound-Guided Acupotomy for Degenerative Cervical Radiculopathy: A Protocol for a Randomized Controlled Trial.
BibTeX
@article{ospanov2026costeffectiveness,
title = {{Cost-effectiveness analysis of FundoRing versus standard one-anastomosis gastric bypass: up to 3-year results of a randomized controlled trial}},
author = {Oral Ospanov and Galymjan Duysenov and Bakhtiyar Yelembayev and Galymzhan Yeleuov and Zhanbolat Dildbekov},
journal = {Annals of medicine and surgery (2012)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13657467},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Cost-effectiveness analysis of FundoRing versus standard one-anastomosis gastric bypass: up to 3-year results of a randomized controlled trial
AU - Oral Ospanov
AU - Galymjan Duysenov
AU - Bakhtiyar Yelembayev
AU - Galymzhan Yeleuov
AU - Zhanbolat Dildbekov
PY - 2026
DA - 2026/09/16
JO - Annals of medicine and surgery (2012)
UR - https://europepmc.org/article/PMC/PMC13657467
SN - 2049-0801
ER -